Champions Oncology (NASDAQ:CSBR) last announced its quarterly earnings data on Thursday, September 14th. The biotechnology company reported ($0.06) earnings per share for the quarter. The business had revenue of $5.03 million during the quarter. Champions Oncology had a negative net margin of 29.87% and a negative return on equity of 338.01%.
Champions Oncology (CSBR) opened at $3.68 on Wednesday. Champions Oncology has a twelve month low of $2.09 and a twelve month high of $4.79.
About Champions Oncology
Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.
Receive News & Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related companies with MarketBeat.com's FREE daily email newsletter.